BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 16/11/2004

FDA Clears DYCLONE Topical Solutions for Approval

The FDA has determined that DYCLONE 0.5% and 1.0% Topical Solutions were not withdrawn from sale due to safety or effectiveness concerns, paving the way for approval of abbreviated new drug applications for these products.

Source: Federal Register — Food and Drug AdministrationOpen original release →